Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel C Mok

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|October 22, 2008
RUNX3 protein is overexpressed in human epithelial ovarian cancerNicole S Nevadunsky, John S Barbieri, Joseph Kwong, et al.
Cancer Genetics and Cytogenetics|August 17, 2005
Ovarian cancer is a heterogeneous diseaseVivian Wang, Cheng Li, Ming Lin, et al.
Cancer Research Communications|October 3, 2025
Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell TumorsEleonora Y Khlebus, Veena K Vuttaradhi, Sammy Ferri-Borgogno, et al.
Cell and Tissue Research|July 2, 2020
Disabled-2: a positive regulator of the early differentiation of myoblastsNa Shang, Juliana Tsz Yan Lee, Taida Huang, et al.
Disease Markers|December 7, 2007
Etiology and pathogenesis of epithelial ovarian cancerSamuel C Mok, Joseph Kwong, William R Welch, et al.
The Journal of Reproductive Medicine|September 9, 2008
Vascularization and expression of angiogenic factors in partial and complete molar pregnanciesZoltan Nagymanyoki, Whitfield B Growdon, Jennifer Sarno, et al.
Gynecologic Oncology|July 6, 2011
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinomaErin R King, Zhifei Zu, Yvonne T M Tsang, et al.
Cancer Research|July 18, 2008
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancerMargarita Aponte, Wei Jiang, Montaha Lakkis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2010
C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and CarboplatinZhijian Gao, Xiaoyin Xu, Bruce McClane, et al.
Cancer Research|February 14, 2023
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer SurvivorsSammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|October 22, 2008
RUNX3 protein is overexpressed in human epithelial ovarian cancerNicole S Nevadunsky, John S Barbieri, Joseph Kwong, et al.
Cancer Genetics and Cytogenetics|August 17, 2005
Ovarian cancer is a heterogeneous diseaseVivian Wang, Cheng Li, Ming Lin, et al.
Cancer Research Communications|October 3, 2025
Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell TumorsEleonora Y Khlebus, Veena K Vuttaradhi, Sammy Ferri-Borgogno, et al.
Cell and Tissue Research|July 2, 2020
Disabled-2: a positive regulator of the early differentiation of myoblastsNa Shang, Juliana Tsz Yan Lee, Taida Huang, et al.
Disease Markers|December 7, 2007
Etiology and pathogenesis of epithelial ovarian cancerSamuel C Mok, Joseph Kwong, William R Welch, et al.
The Journal of Reproductive Medicine|September 9, 2008
Vascularization and expression of angiogenic factors in partial and complete molar pregnanciesZoltan Nagymanyoki, Whitfield B Growdon, Jennifer Sarno, et al.
Gynecologic Oncology|July 6, 2011
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinomaErin R King, Zhifei Zu, Yvonne T M Tsang, et al.
Cancer Research|July 18, 2008
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancerMargarita Aponte, Wei Jiang, Montaha Lakkis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2010
C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and CarboplatinZhijian Gao, Xiaoyin Xu, Bruce McClane, et al.
Cancer Research|February 14, 2023
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer SurvivorsSammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, et al.
Pageof 15